Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical coal tar versus topical corticosteroids in children with moderate to severe atopic dermatitis
NL-OMON42910Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2018
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in atopic dermatitis (AD) comparing Topical coal tar with Moderate-potency topical corticosteroids (2 arms). Primary endpoint: Percentage change in EASI score at week 2. Started Mar 2018; status: active, not recruiting.
02
Drugs
coal tarcorticosteroids
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON42910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42910.